Speciality Medicines Approves FY26 Directors' Report and Schedules 5th AGM
Speciality Medicines Ltd 路 Others (Uncategorized) 路 03 Sept 2026, 9:20 pm
Speciality Medicines Approves FY26 Directors' Report and Schedules 5th AGM Speciality Medicines Limited's board met on 3rd Sep'26 to approve the Draft Directors' Report for FY25-26. The company scheduled its 5th Annual General Meeting (AGM) for 28th Sep'26 via video conferencing. The cut-off date to determine e-voting eligibility is 21st Sep'26. Share transfer books will remain open as all shareholdings are entirely dematerialized. NSDL has been appointed as the remote e-voting agency, and CS Hardikkumar Jetani will act as the scrutinizer to ensure a fair e-voting process for the upcoming AGM.
Original exchange filing (PDF)
More announcements from Speciality Medicines Ltd
- We hereby submit the Standalone Unaudited Financial Result for the half year ended on September 30, 2026 路 12 Nov 2026
- We hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on November 12, 2026, at the Corporate Office of the Company which was commenced .... 路 12 Nov 2026
- Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve 1. Unaudited Standalone .... 路 12 Nov 2026
- We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company. 路 28 Sept 2026
- We hereby submit Proceedings of 5th AGM of the Company. 路 28 Sept 2026
- We hereby Submit Annual Report of FY 2025-26. 路 04 Sept 2026
- We hereby submit Notice of 5th AGM to be held on September 28, 2026. 路 04 Sept 2026
- We hereby submit intimation regarding approval for Two new products in Ethiopia. 路 12 Aug 2026
